ClinicalTrials.gov
public full text
Public Domain
A Study of LY3305677 in Healthy Participants
The purpose of this study is to evaluate the safety of LY3305677 and any side effects that might be associated with it. This study will also look at how much LY3305677 gets into the blood stream, how long it takes the body to remove it. This study involves a single dose of LY3305677 administered by subcutaneous injection (SC). Participation in this study is expected to last up to 16 weeks.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis#1162443
- A Study of LY3143753 and LY3185643 in Healthy Participants#1162461
- A First-in-Human Study of LY3009385 in Healthy Participants#837388
- A Study of LY2801653 in Healthy Participants Who Are Not Able to Have Children#1088733
- A Study of LY3541860 in Healthy Japanese and Non-Japanese Participants#890571
Record · ID 918606
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive